UK should be “proud” of service and supply sector
Service and supply companies account for 80% of small and medium enterprises (SMEs) in UK medicines discovery, and 90% of employment.
Read More
Tag: SMEs
Report calls for urgent action on R&D model
“Urgent action” is required to boost the productivity of the UK’s R&D model, which is grappling with “unprecedented pressure”, claims a new report by Medicines Discovery Catapult and the BioIndustry Association.
Read More
Gov’t unveils £86m package to support SMEs
Health minister Lord O’Shaughnessy has unveiled a new package of support worth up to £86 million to help innovative UK businesses develop medical breakthroughs that are then used across the NHS.
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
